What Researchers Did
Researchers combined the results of 42 studies to see how well dental implants survive in people who were treated for head and neck cancer, and what factors affect that survival.
What They Found
This meta-analysis of 42 studies (2,448 patients, 10,164 implants, follow-up ranging from 1 to 12 years) found an overall pooled implant survival rate of 88 percent (95% CI: 85 to 90 percent). Implant survival was lower in bone that had been irradiated compared to non-irradiated bone (18 studies, RR 0.95, 95% CI: 0.91 to 0.99, p equals 0.03), and lower in grafted bone compared to native bone (15 studies, RR 0.92, 95% CI: 0.88 to 0.97, p less than 0.001). Separately, implant survival rates were higher in patients who had undergone hyperbaric oxygen therapy compared to those who had not (5 studies, RR 1.47); the abstract does not report this HBO comparison broken down by irradiated or grafted bone status. Heterogeneity across the included studies was high (I squared equals 94.9 percent, p less than 0.001).
What This Means for Canadian Patients
For patients treated for head and neck cancer who are considering dental implants, this pooled data suggests that having irradiated or grafted bone is linked to somewhat lower implant survival, while having had hyperbaric oxygen therapy is linked to higher implant survival in this dataset overall. Because this is a meta-analysis of observational studies rather than randomized trials, it cannot show that hyperbaric oxygen therapy caused the better outcomes, and the abstract does not report whether this benefit applies specifically to patients with irradiated or grafted bone.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The included studies varied widely in design and follow-up length, heterogeneity between studies was very high (I squared equals 94.9 percent), and the pooled survival rate reflects crude proportions rather than time-specific estimates, so the findings should be interpreted with caution.